Doxorubicin and cyclophosphamide followed by weekly docetaxel (AC-T) as neoadjuvant chemotherapy in operable breast cancer patients:: GEICAM 2002-03 Study

被引：0
|
作者：
Estévez, LG
Adrover, E
Barnadas, A
Cuevas, JM
Seguí, MA
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [41] Role of proliferation in response to neoadjuvant chemotherapy in GEICAM/2006-03 and GEICAM/2006-14 breast cancer patients.
    Alba, E.
    Albanell, Joan
    Chacon Lopez-Muniz, Jose Ignacio
    Calvo, Lourdes
    De la Haba-Rodriguez, Juan
    Sanchez Rovira, Pedro
    Plazaola, Arrate
    Barnadas, Agust
    Angel Segui-Palmer, Miguel
    Arcusa Lanza, Angels
    Ramos Vazquez, Manuel
    Rojo, Federico
    Burgues, Octavio
    Pajares, Bella
    Bermejo, Begona
    Sanchez-Munoz, Alfonso
    Isabel Casas, Maria
    Caballero, Rosalia
    Maria Carrasco, Eva
    Lluch, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)
    Ruoyang Li
    Fuguo Tian
    Yixin Qi
    Li Ma
    Tao Zhou
    Yuntao Li
    Tianli Hui
    Lina Zhang
    Shuo Wang
    Zhenchuan Song
    Scientific Reports, 9
  • [43] Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)
    Li, Ruoyang
    Tian, Fuguo
    Qi, Yixin
    Ma, Li
    Zhou, Tao
    Li, Yuntao
    Hui, Tianli
    Zhang, Lina
    Wang, Shuo
    Song, Zhenchuan
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [44] Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in operable breast cancer: Results of Intergroup Trial E1199
    Sparano, J. A.
    Wang, M.
    Martino, S.
    Jones, V.
    Perez, E.
    Saphner, T.
    Wolff, A. C.
    Sledge, G. W., Jr.
    Wood, W. C.
    Davidson, N. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+early breast cancer
    Slamon, D. J.
    Eiermann, W.
    Robert, N. J.
    Giermek, J.
    Martin, M.
    Jasiowka, M.
    Mackey, J. R.
    Chan, A.
    Liu, M-C
    Pinter, T.
    Valero, V.
    Falkson, C.
    Fornander, T.
    Shiftan, T. A.
    Bensfia, S.
    Hitler, S.
    Xu, N.
    Bee-Munteanu, V.
    Drevot, P.
    Press, M. F.
    Crown, J.
    CANCER RESEARCH, 2016, 76
  • [46] Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
    Kim, Chang Gon
    Sohn, Joohyuk
    Chon, Hongjae
    Kim, Joo Hoon
    Heo, Su Jin
    Cho, Hyunsoo
    Kim, In Jung
    Kim, Seung Il
    Park, Seho
    Park, Hyung Seok
    Kim, Gun Min
    JOURNAL OF BREAST CANCER, 2016, 19 (01) : 76 - 82
  • [47] Primary systemic therapy using docetaxel/cyclophosphamide/bevacizumab (TCB) followed by doxorubicin (A) in operable or locally advanced breast cancer (BC)
    Makhoul, I.
    Klimberg, S.
    Henry-Tillman, R.
    Westbrook, K.
    Korourian, S.
    Siegel, E.
    Hutchins, L.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 592 - 593
  • [48] Primary systemic therapy using docetaxel/cyclophosphamide/bevacizumab (TCB) followed by doxorubicin (A) in operable or locally advanced breast cancer (BC)
    Makhoul, I
    Klimberg, S.
    Henri-Tillmen, R.
    Westbrook, K.
    Hutchins, L.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S224 - S225
  • [49] A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
    Cheng, Meng
    Song, Zhenchuan
    Qi, Yixin
    Wang, Xinle
    Zhang, Lina
    Shi, Jiajie
    Wang, Mingxia
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (05) : 269 - 274
  • [50] Neoadjuvant chemotherapy for breast cancer (BC): Is doxorubicin-cyclophosphamide (AC) combination still a standard regimen?
    Fumoleau, P
    Dieras, V
    Romieu, G
    Tubiana-Hulin, M
    Namer, M
    Maurice, L
    Guastalla, JP
    Kerbrat, P
    Martinez, A
    Pouillart, P
    Gauducheau, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S229 - S230
12345